Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30

$0.65+0.03 (+4.13%)

Close on Nov 13, 2026Market cap $15.23MP/E –Yield –

Genenta Science S.p.A. statistics

51 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Dec 31, 2025
Share price as of: –

Valuation ratiosIndustry

Market Cap: €13.65M; €768.08M
Enterprise Value: -€14.50M; €535.62M
PB Ratio: 0.63; 0.63
P/TBV Ratio: 0.63; 1.33

Share statisticsIndustry

Shares Outstanding: 23M; 100M
Shares Change (YoY): 7.86%; 5.61%
Float: 16M; 79M
Shares Held by Insiders: 33.5%; 9.05%
Shares Held by Institutions: 3.08%; 20.8%

Stock price statisticsIndustry

Price Change (1 Week): -2.29%; 0.08%
Price Change (1 Month): -2.93%; -2.76%
Price Change (3 Months): -48.4%; -21.7%
Price Change (6 Months): 3.47%; -11.3%
Price Change (YTD): -56.4%; -15.5%
Price Change (1 Year): -70.7%; -17.6%
Price Change (3 Years): -87.5%; -8.10%
Average Volume (10 Days): 247,288; –
Average Volume (20 Days): 151,228; –
Average Volume (90 Days): 80,679; –
Relative Volume: 0.23; 0.63
Relative Strength Index (14): 46.2; 48.4
Volatility (1 Year): 131.2%; 65.2%
Beta (5 Years): 0.26; 0.86

Returns on capitalIndustry

Return on Equity (ROE): -38.0%; -15.4%
Return on Assets (ROA): -28.0%; -1.57%
Return on Capital Employed (ROCE): -22.2%; -23.8%

Financial positionIndustry

Current Ratio: 14.16; 3.49
Quick Ratio: 13.29; 1.51

EfficiencyIndustry

Profits Per Employee: -€502.29K; -€43.26K
Employee Count: 13; 304
WACC: 7.60%; 9.49%

Income statement (TTM)Industry

Operating Income: -€6.60M; -€54.01M
Pretax Income: -€6.53M; -€47.40M
Net Income: -€6.53M; €157.18M
EBITDA: -€6.58M; -€42.85M
EPS (Diluted): -0.33 EUR; -0.55 EUR

Balance sheetIndustry

Cash & Short-Term Investments: €28.15M; €199.29M
Net Cash (Debt): €28.15M; €111.50M
Net Cash Per Share: 1.20 EUR; 1.53 EUR
Equity (Book Value): €21.84M; €472.30M
Book Value Per Share: 0.93 EUR; 6.00 EUR
Tangible Book Value: €21.84M; €50.66M
Working Capital: €27.86M; €119.55M

Cash flow (TTM)Industry

Operating Cash Flow: -€6.87M; -€42.16M
Capital Expenditures: -€7.63K; -€2.34M
Free Cash Flow: -€6.88M; -€52.90M
FCF Per Share: -0.29 EUR; -0.48 EUR

Dividends and yieldsIndustry

Earnings Yield: -47.8%; -1.80%
FCF Yield: -50.4%; -13.3%

Scores and fair valueIndustry

Altman Z-Score: -1.57; 1.23
Piotroski F-Score: 4; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	SAEN	S&P 500	Difference	SAEN per year	S&P 500 per year
1 month	-10.0%	-3.0%	−7.0 pts
3 months	-50.0%	-2.8%	−47.2 pts
Year to date	-56.4%	+11.5%	−67.9 pts
1 year	-70.2%	+13.5%	−83.7 pts
3 years	-88.2%	+77.7%	−165.9 pts	-50.9%	+21.1%

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?